Pennant Investors, LP Uni Qure N.V. Transaction History
Pennant Investors, LP
- $367 Million
- Q2 2024
A detailed history of Pennant Investors, LP transactions in Uni Qure N.V. stock. As of the latest transaction made, Pennant Investors, LP holds 48,500 shares of QURE stock, worth $306,035. This represents 0.06% of its overall portfolio holdings.
Number of Shares
48,500
Previous 48,500
-0.0%
Holding current value
$306,035
Previous $252,000
13.89%
% of portfolio
0.06%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding QURE
# of Institutions
141Shares Held
34.8MCall Options Held
1.54MPut Options Held
389K-
Vestal Point Capital, LP New York, NY4.75MShares$30 Million1.59% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.65MShares$16.7 Million0.79% of portfolio
-
Abrdn PLC1.93MShares$12.2 Million0.02% of portfolio
-
Black Rock Inc. New York, NY1.93MShares$12.2 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY1.9MShares$12 Million0.78% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $295M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...